Please Wait
Applying Filters...
menu
    • menu
    Towa Pharmaceutical-PSE
    News
    Enforcement Report - Week of January 1, 2025

    01 Jan 2025

    // FDA

    FDA Recalls Thousands Of Duloxetine Antidepressant Bottles

    23 Oct 2024

    // TIMESNOWNEWS

    Enforcement Report - Week of October 23, 2024

    23 Oct 2024

    // FDA

    Data Compilation
    #PharmaFlow

    Towa Pharmaceutical

    Contact Supplier

    Website

    PharmaVenue

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/prL_A0I4ZVQ
    Menu

    Towa Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/towa-pharmaceutical-party-content-2847.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 1, 2025
    Enforcement Report - Week of January 1, 2025

    01 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-1-2025-88420.pdf

    FDA
    01 Jan 2025
    Share Share
    FDA Recalls Thousands Of Duloxetine Antidepressant Bottles
    FDA Recalls Thousands Of Duloxetine Antidepressant Bottles

    23 Oct 2024

    // TIMESNOWNEWS

    https://www.timesnownews.com/world/us/us-news/fda-recalls-thousands-of-duloxetine-antidepressant-bottles-heres-why-article-114478047

    TIMESNOWNEWS
    23 Oct 2024
    Share Share
    Enforcement Report - Week of October 23, 2024
    Enforcement Report - Week of October 23, 2024

    23 Oct 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2024-21885.pdf

    FDA
    23 Oct 2024
    Share Share
    Acquired approval for manufacturing and marketing generic drugs
    Acquired approval for manufacturing and marketing generic drugs

    15 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240815.pdf

    PRESS RELEASE
    15 Aug 2024
    Share Share
    FY2024 Supplementary Material of Financial Results 1Q
    FY2024 Supplementary Material of Financial Results 1Q

    08 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/slide69a.pdf

    PRESS RELEASE
    08 Aug 2024
    Share Share
    Notice of Financial Results of Parent Company, etc.
    Notice of Financial Results of Parent Company, etc.

    25 Jun 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240625_4.pdf

    PRESS RELEASE
    25 Jun 2024
    Share Share